Why the study?
Does clenbuterol reduce EFS-induced contractile responses in rat mesenteric arteries without endothelium?
Population
Rat mesenteric artery segments without endothelium
Comparison
Clenbuterol (1 microM) vs Control and various antagonists/inhibitors
Design
Preclinical
Authors
Loading...
No immediate clinical implications from rodent data; extends beta2-NO signaling research to mesenteric nerves.
Does clenbuterol reduce EFS-induced contractile responses in rat mesenteric arteries without endothelium?
Clenbuterol reduces EFS-induced contraction in rat mesenteric arteries via nitric oxide release, likely through beta2-adrenoceptor activation on nitrergic nerves.
Marı́n et al. (1998) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: